Assessing atrial fibrillation ablation priority during COVID-19 -does use of patient questionnaires help in stratification above physician assessment?
| Autor: | Simon Modi, Derick Todd, Johan E.P. Waktare, Saagar Mahida, Z. Borbas, Vishal Luther, R. Ashrafi, Mark C.S. Hall, Dhiraj Gupta, Richard Snowdon, H. Ahmad, C. Pius |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) business.industry medicine.medical_treatment Geriatric assessment Atrial fibrillation Catheter ablation Ablation medicine.disease Symptomatic relief Quality of life Physiology (medical) Hospital admission Emergency medicine medicine AcademicSubjects/MED00200 Atrial Fibrillation (AF) - Clinical Cardiology and Cardiovascular Medicine business |
| Zdroj: | Europace |
| ISSN: | 1532-2092 1099-5129 |
| DOI: | 10.1093/europace/euab116.292 |
| Popis: | Funding Acknowledgements Type of funding sources: None. Introduction Catheter ablation for atrial fibrillation (AF) is largely offered for symptomatic relief. The ORBIT registry has shown that patients with a higher EHRA class and lower quality of life (QoL) scores (AFEQT score |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|